Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_provenance.
- NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_assertion wasGeneratedBy ECO_0000203 NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_provenance.
- NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_assertion wasDerivedFrom befree-2016 NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_provenance.
- NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_assertion SIO_000772 21039418 NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_provenance.
- NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_assertion evidence source_evidence_literature NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_provenance.
- NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_assertion description "[Clinical results of osanetant and talnetant (selective-NK₃ antagonists) indicate that blocking the NK₃ receptor could be beneficial for the treatment of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849499.RAX7Q-g-B-m9qJ4iHWsN8aCJo-_XXz9NVTaLBD7JQFTiQ130_provenance.